|
Numerous signal
transduction processes involve lipids as signaling molecules. Many
of these molecules are generated by phospholipases such as
phospholipase A2,
which releases fatty acids like arachidonic acid, and lysophospholipids. Each of these products is implicated in signal
transduction processes, but also serves as a precursor for platelet
activating factor or the eicosanoids. The eicosanoids
are a large family of bioactive mediators that derive from the enzymatic
oxygenation of arachidonic acid. Prostaglandins, leukotrienes, thromboxane, lipoxins, are all members of the eicosanoid
family. The eicosanoids are biomedically important because they
mediate all four signs of inflammation, namely heat, redness,
swelling and pain. Controlling the formation of eicosanoids has been
found to be of great benefit for the treatment of acute and chronic
inflammatory diseases.
Lipid signaling
is also key to the development of diabetes and the myriad of
metabolic diseases associated to it (e.g. obesity, metabolic
syndrome, cardiovascular disease, etc). Of note, many of the enzymes
involved in glycerolipid biosynthetic pathways may act to initiate
intracellular signaling.
While our long-term goals include all kinds of enzymes
potentially involved in lipid signaling, our current research focuses primarily on
phospholipase A2
and phosphatidate phosphohydrolase (phosphatidic acid-specific
phospholipase C; lipin). General events that we are interested in
include (i) the spatiotemporal regulation of these phospholipases in
a cellular context, which we study utilizing advanced microscopy
techniques, (ii) pharmacological manipulation of enzymatic activity
both in intact cells and in vitro, (iii) analysis of lipid
metabolite production by state-of-the-art mass spectrometry (lipidomics
& metabolipidomics), and (iv) the physiological functioning of
phospholipases in animal models.
Ongoing studies are focusing on the localization and stimulus-driven
translocation of different members of the phospholipase A2
and lipin families. Phospholipase A2s cleave the fatty acid at the sn-2 position of
phospholipids and thus constitute the earliest regulatory point of
the eicosanoid biosynthetic cascade. Lipins dephosphorylate
phosphatidic acid to form diacylglycerol, which is used for the
biosynthesis of glycerophospholipids and triacylglycerol. Current studies are being
carried out by transfecting chimeric constructs of green fluorescent
protein (GFP) (or any of its colored varieties) with the appropriate phospholipase. GFP
is placed at either the N- or C-termini. of the
enzymes. These constructs provide a very useful tool to visualize
the intracellular movements of the enzymes
in response to the different stimuli. Mutagenesis studies are also
being conducted to pinpoint the specific amino acids of the phospholipase A2s
and lipins that are implicated in the movement among intracellular
compartments.

Another of our goals is to apply a lipidomics approach to the
study of the mechanisms governing the availability and oxidative
metabolism of free arachidonic acid during activation of
macrophages by stimuli of the innate immune response. Availability
of free arachidonate is a limiting step for the synthesis of eicosanoids.
While the pathways of fatty acid uptake, incorporation and remodeling in
glycerolipids are well documented, the individual lipid species in
which arachidonate is stored and released from have not been identified.
This is so because of the impossibility of traditional methods for
lipid separation (i.e. thin-layer chromatography, liquid
chromatography) to differentiate among individual lipids within
various classes and subclasses. This is now possible with the advent
of electrospray mass spectrometry (ESI-MS). Application of this
technology to the field of lipid biochemistry has been a major
breakthrough in profiling the lipidomes of cells and tissues in
physiological and pathophysiological conditions. We are conducting a lipidomics analysis of all the lipid molecular species involved in
arachidonic acid homeostasis, from those that act as acceptors of the fatty acid
to those from which the fatty acid is liberated for subsequent eicosanoid synthesis, and including as well a full survey of
arachidonate-derived
oxygenated metabolites.
 |